Neal Shore

69PUBLICATIONS
253CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsChemotherapyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (69)

|Jul 09, 2026
Enzalutamide in biochemically recurrent prostate cancer: clinical implications from EMBARK for real-world practice.

|Jun 25, 2026
Real-world clinical outcomes and economic burden of discontinuation of taxane therapy among patients with metastatic castration-resistant prostate cancer.

|Jun 20, 2026
Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial.

|Jun 02, 2026
Phase 1b trial of Bavdegalutamide (ARV-110) in combination with Abiraterone for metastatic prostate cancer.

|Jun 01, 2026
Ceralasertib Monotherapy in Patients with ATM-Altered Advanced Solid Tumors or Metastatic Castration-Resistant Prostate Cancer: Data from the Phase IIa PLANETTE Study.

|May 11, 2026
Detection of Homologous Recombination Repair Gene Mutations by Tumor Tissue and Circulating Tumor DNA Testing in Prostate Cancer in the Phase III PROpel Trial.

Pageof 12

Frequent Collaborators

6 joint publications

Fred Saad

5 joint publications

Emmanuel S Antonarakis

5 joint publications

Alicia K Morgans

5 joint publications

Rana R McKay